The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aeglea BioTherapeutics | COM | 00773J103 | 29 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
| Akari Therapeutics Plc | COM | 00972G108 | 2,136 | 158,352 | SH | SOLE | 158,352 | 0 | 0 | ||
| Alcobra Ltd | COM | M2239P109 | 2,799 | 623,313 | SH | SOLE | 623,313 | 0 | 0 | ||
| ARCA biopharma Inc | COM | 00211Y100 | 1,341 | 462,399 | SH | SOLE | 462,399 | 0 | 0 | ||
| Ascendis Pharma A/S | COM | 04351P101 | 1,194 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| Adverum Biotechnologies | COM | 00773U108 | 3,485 | 1,102,735 | SH | SOLE | 1,102,735 | 0 | 0 | ||
| Axovant Sciences Ltd | COM | G0750W104 | 2,364 | 184,110 | SH | SOLE | 184,110 | 0 | 0 | ||
| BioCryst Pharmaceuticals Inc | COM | 09058V103 | 2,854 | 1,005,104 | SH | SOLE | 1,005,104 | 0 | 0 | ||
| BeiGene Ltd | COM | 07725L102 | 1,520 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 10,320 | 611,010 | SH | SOLE | 611,010 | 0 | 0 | ||
| Cynapsus Therapeutics Inc | COM | 23257Y701 | 1,806 | 108,575 | SH | SOLE | 108,575 | 0 | 0 | ||
| CytomX Therapeutics Inc | COM | 23284F105 | 656 | 64,200 | SH | SOLE | 64,200 | 0 | 0 | ||
| DBV Technologies | COM | F2927N109 | 29,114 | 456,893 | SH | SOLE | 456,893 | 0 | 0 | ||
| Edge Therapeutics Inc | COM | 279870109 | 1,365 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| Flamel Technologies S.A. | COM | 338488109 | 5,370 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| Global Blood Therapeutics | COM | 37890U108 | 1,211 | 72,990 | SH | SOLE | 72,990 | 0 | 0 | ||
| Heron Therapeutics Inc | COM | 427746102 | 19,778 | 1,095,734 | SH | SOLE | 1,095,734 | 0 | 0 | ||
| Lipocine Inc | COM | 53630X104 | 2,584 | 849,921 | SH | SOLE | 849,921 | 0 | 0 | ||
| Ocera Therapeutics | COM | 67552A108 | 1,513 | 796,550 | SH | SOLE | 796,550 | 0 | 0 | ||
| ProNAI Therapeutics Inc | COM | 74346L101 | 112 | 56,056 | SH | SOLE | 56,056 | 0 | 0 | ||
| REGENXBIO Inc | COM | 75901B107 | 420 | 52,500 | SH | SOLE | 52,500 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 917 | 135,420 | SH | SOLE | 135,420 | 0 | 0 | ||
| Zafgen Inc | COM | 98885E103 | 3,607 | 602,114 | SH | SOLE | 602,114 | 0 | 0 | ||